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S390 Poster Session IIPurpose: On a 36-bed stem cell transplant unit at a small NCI
–designated medical center, the shift report was unstructured, vari-
able, time-consuming and often repetitive.Research has shown that
incorporating change of shift report at the bedside not only iden-
tifies safety concerns but also facilitates continuity of care, and
drives staff accountability and responsibility. By having two nurses
examine the patient in unison at the change of shift, it was hypoth-
esized that a decrease in falls, medications errors, and miscommu-
nication would occur.
Intervention: After conducting a literature search regarding bed-
side handover, the educator for the stem cell unit worked with
the unit based council of the unit to create a process for imple-
menting bedside handover. A survey was conducted to evaluate
the knowledge of the nursing staff regarding bedside handover as
well as their willingness to change practice. Newsletters, flyers,
and discussions at staff meetings were done two months before
roll-out. Scripts were created along with letters to the patients to
provide a level of comfort this change would bring. Staff would re-
view the highlights of the night in their standard format at the
nursing station but would then go to the bedside to focus on per-
tinent issues such as pump settings, skin assessment, and a safety
check.
Evaluation: A 3 month trial period was conducted with overall pos-
itive results. Staff was re-surveyed at the end of the three months to
assess the change and solicit suggestions for improvement. Results of
these evaluations will be discussed.
Discussion: As patient co-morbidities increase and acuity continues
to rise, bedside clinicians need to be vigilant in keeping patients safe.
It was important to implement a process that would have positive re-
sults for both the staff and patients. Incorporating bedside handover
into the shift report process has been well received and is now a stan-
dard part of shift report.510
MANAGEMENT OF EMERGENT PATIENT CARE IN THE OUTPATIENT
SETTING
Noonan, M.J. Duke University, Durham, NC
The transplant process in the outpatient setting can be very chal-
lenging. Given our ability to treat a wider range of patients increases
these challenges. In a traditional inpatient, hospital setting there is
a clear, defined process for dealing with medical emergencies. Typ-
ically there are two levels of response: an RRT – a rapid response
teamwhich can be called when a patient decompensates prior to their
full arrest and the classic CODE team which responds to patients in
full arrest. In the outpatient setting, particularly one that is removed
from the main hospital campus these options do not exist. In an at-
tempt to improve the response to these patients an emergency plan
was developed.
The outpatient clinic has two traditional code carts available.
As their full contents are rarely needed and their cost can be sig-
nificant, staff was provided an emergency kit which could be eas-
ily carried to the patient in an emergent situation. This mobility
is of vital importance in a clinic that is large and covers a variety
of patient care areas. This kit has all the basic supplies to initially
stabilize a decompensating patient. It includes IV fluids, vascular
access supplies and oxygen delivery devices. Also available are an
AED and mobile blood pressure and basic 3 lead cardiac
monitoring.
Due to the fact we are separate of the hospital campus in some
ways and others not, confusion ensued when patients required trans-
port to the hospital. Arrangements have been made with our affili-
ated Life Flight team and local EMS for transport of our patients
who require medical care beyond the scope of our clinic. Our hospi-
tal Life Flight ground transport team is contacted to provide trans-
port for patients who need hospital admission but are clinically
stable for treatment in our inpatient BMT unit. The local county
EMS is contacted for patients who require care in an emergent life
threatening situation. The use of these two entities has greatly
streamlined the transport process for patients who require different
levels of emergent care.
By eliminating confusion in an emergent situation improved
care is provided to the patient. All materials are readily availableto staff and there is a clear, defined plan for patient transport
when needed.
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JUST IN TIME TRAINING, TRAVEL NURSES: UNIT SPECIFIC COMPETENCY
FOR ADULT INPATIENT BONE MARROW TRANSPLANT
Grant-Navarro, P., Choo, K., Wallace, M.H., Feustel, J. Memorial Sloan
Kettering Cancer Center, New York, NY
Significance & Background: Travel nurses are often used to sup-
plement staffing requirements in hospital settings. The Adult Bone
Marrow Transplant inpatient unit at this NCI- designated Compre-
hensive Cancer Center required the use of Travel nurses to ensure an
adequate nurse to patient ratio. Bone Marrow Transplant patients
have complex care needs requiring specialized nursing knowledge.
One advantage of utilizing Travel RN’s is the rapid stabilization of
staffing ratios.
Purpose: The purpose of this Just in Time Travel RN Orientation
was to ensure the delivery of competent, high quality nursing care
and continue to maintain a high level of patient satisfaction in the
category ‘‘skill of the nurse’’.
Interventions: Implementation of the program began in the second
quarter of 2011. It was developed to provide a didactic component to
existing Travel RN orientation incorporating unit specific work-
flow’s and specialized core competencies. To support teaching and
serve as a resource for the Travel RN an educational binder was cre-
ated. To evaluate competency a written exam was developed and ad-
ministered post training. An RN is assigned daily to function as
a resource for the Travel RN to facilitate continued learning and in-
dependent care delivery.
Evaluation:Anticipating significant RN functional vacancies the use
of Travel RN’s provided an effective staffing solution. Following im-
plementation of the Just in Time orientation program staffing needs
are being met with the addition of two full-time Travel RN’s. The
post training competency exam has been administered with satisfac-
tory results. Measurement of patient satisfaction of the component
‘‘skill of the nurse’’ remains high.
Discussion: We believe this unique program ensures the ability of
Travel RN staff to work together with core staff as a cohesive unit
delivering competent and skillful nursing care to the complex bone
marrow transplant patient.512
FAECAL MANAGEMENT DEVICES AND SEVERE GRAFT VERSUS HOST DIS-
EASE
Wood, A., Savage, C., Liebersbach, S., Davis, N., Mazumdar, R.,
Pol, R., Cook, G., Gilleece, M. St James’s University Hospital, Leeds,
United Kingdom
We present our updated experience of the Flexiseal faecal
management device (FMD) in the care of patients with acute
Graft Vs Host Disease (GVHD) of the bowel. Acute GVHD
complicates allogeneic haemopoietic stem cell transplantation
(HSCT) in 10-80%. The gut, along with skin & liver is targeted
& lower gut involvement is characterised by profuse diarrhoea.
Faecal incontinence (FI) increases the risk of perineal ulceration.
In their study of 2,189 patients, Maklebust & Magnan (1994)
found that FI was a stronger predictor of ulcer risk than other
factors, including impaired mobility & malnutrition. The risk
of ulceration was 22x greater if FI was present. The FMD is
a temporary containment system consisting of a soft flexible, sil-
icone catheter with a low-pressure balloon, filled with water to
aid retention & attached to a stool collection bag for \ 28
days. The FMD is easy to insert & promotes a) patient comfort
& dignity, b) reduced infection rates, c) release of nursing time
& d)cost reduction (Binks, 2007, Padmanabhan, 2007). The ap-
plication of the FMD post-HSCT was not previously reported
until 2010 (Wood, EBMT, 2010). We update our report of
the use of the FMD in FI due to GVHD. All four patients
had severe acute GVHD bowel (.1500 mls of diarrhoea/day
with abdominal pain &/or ileus). We observed the use of the
FMD in the critical care setting in the management of GVHD
post-liver transplant. In our own practice we then used an
Poster Session II S391FMD in the palliative management of an unconscious patient
with Glucksberg Grade IV GVHD gut post HSCT. Use of
the device over the final 5 days of life was uneventful. Following
this experience we have gone on to use the FMD successfully in
3 further patients with severe acute GVHD gut post-HSCT. Ob-
served direct benefits for the patients include promotion of dig-
nity, facilitation of uninterrupted rest, absence of odour,
reduction of embarrassment and more comfortable access to vis-
itors. Clinical benefits included improved accuracy of fluid bal-
ance assessment, maintenance of skin integrity, absence of
healthcare associated infections & the ability to devote more
nursing time to the other needs of the patient. Our only negative
finding was that the FMD can leak, however this is minimal, and
can be reduced by regular flushing of the device. The device was
replaced every 28 days and was in use for up to 63 days, without
complications. We have found the FMD to promote the effective
& compassionate care of patients with severe GVHD gut.513
COLLABORATING WITH OUR COLLEAGUES TO ENHANCE CARE: A MUL-
TIDISCIPLINARY WORKFLOW FOR BUSULFAN PK SERUM LEVELS
Choo, K., Grant Navarro, P., Wallace, M.H. Memorial Sloan Kettering
Cancer Center, New York, NY
Significance and Background: Busulfan is administered as part of
a myeloblative conditioning regimen for allogeneic hematopoietic
stem cell transplant. Plasma pharmacokinetic analysis (PK) is used
to determine a patient’s Busulfan serum level. Maintaining therapeu-
tic levels of Busulfan decrease the risk of Busulfan related toxicity,
graft rejection and disease progression. In 2011 this NCI-designated
Comprehensive Cancer Center initiated processing of PK levels in-
stead of sending them to another facility almost 3000miles away.We
believe patient care is improved as the results are obtained the same
day instead of the next day providing the opportunity to adjust the
4th dose versus the 7th dose. This practice change required effective
collaboration between nursing, medicine, pharmacy and the clinical
laboratory.
Purpose:The purpose of in-house pharmacokinetic analysis (PK) is
to obtain results the same day and adjust the dose as necessary to
maintain a therapeutic serum level.
Interventions: Amultidisciplinary team developed a new RNwork-
flow for obtaining specifically timed specimens, an LIP order set, an
electronic notification when a Busulfan order is initiated, a workflow
for storing and transporting the specimens to the lab and a workflow
for the lab to verify receipt of specimens. A multidisciplinary educa-
tion plan was developed educating the medical, nursing, pharmacy
and clinical laboratory staff regarding the new in-house Busulfan
PK level process.
Evaluation: As a result of the new Busulfan PK level process,
levels are obtained with the first dose of Busulfan and results
are reported in the afternoon. On evening rounds, a determination
is made whether to adjust the 4th dose of Busulfan considering the
PK result.
Discussion:We believe that being able to adjust the dose of Bu-
sulfan earlier in the treatment process may help maintain a ther-
apeutic level enhancing the chance of a successful transplant
outcome.514
SAME QUALITY, FEWER RESOURCES: PREPARING PATIENTS FOR DIS-
CHARGE AFTER HEMATOPOIETIC STEM CELL TRANSPLANT
Blackburn, R.K., Doyle, K., Jewell, J. University of Texas MD Anderson
Cancer Center, Houston, TX
Background: Preparing for hospital discharge following hemato-
poietic stem cell transplantation (HSCT) involves extensive multi-
disciplinary teaching to patients and caregivers. Historically this
has been accomplished with printed materials, individualized teach-
ing, and formal group classes held weekly on the HSCT inpatientunit—a strategy that is labor and resource intensive, and inconve-
nient for out of town caregivers.
Purpose: The nursing leadership on a 64 bed HSCT unit at
a NCI-designated cancer center identified a need for patient/
caregiver educational methods that provided opportunities for pa-
tients to view repeatedly, and for their caregivers to view from
home.
Intervention: A multidisciplinary health care team from the
HSCT unit developed scripts for 16 minute discharge films aimed
at either allogeneic or autologous patients that could be viewed on
television through the patient education system in patient rooms,
or could be accessed as 2 minute segments in links through the in-
stitutional intranet. Caregivers receive access from HSCT patients
to view the web based chapters that cover all aspects of care after
discharge.
Evaluation: For one month HSCT inpatients viewed both the
video, and attended the existing 1 hour discharge class, and then
completed an evaluation of which form of education they preferred.
Of the 38 evaluations returned, patients overwhelming reported
that the content covered in the video prepared them for discharge,
and appreciated the ability to view it repeatedly in the comfort of
their room. Patients did, however, request an opportunity to ask
questions in a live format. Based on these results, 30 min weekly
question and answer sessions were scheduled that patients/families
may attend after viewing the video. Attendance at these sessions has
been low, as many patients feel the videos adequately addressed
their concerns.
Discussion:One of the biggest challenges facing healthcare organi-
zations in today’s economic climate is maintaining high quality pa-
tient care programs with fewer financial resources. Preparing
HSCTpatients for discharge from the hospital involves extensive ed-
ucation of complex post transplant guidelines. Moving from labor
and resource intensive individual classes to film and web based appli-
cations are useful ways to assure patient education content is thor-
oughly covered. Providing 30-minute weekly scheduled question
and answer sessions allows patients an opportunity to have concerns
addressed.515
NON-PHARMACOLOGICAL STRATEGIES TO PREVENT NEUTROPENIC FE-
VER IN HEMATOLOGIC MALIGNANCY
Weiner, H., Lunsford, V., Potter, P. Barnes Jewish Hospital, St. Louis,
MO
Neutropenia is often an inevitable part of treating hematologic
malignancies. It is the most common cause of limiting the dose of
chemotherapy and if neutropenia occurs, it puts a patient at
a much higher risk of developing an infection that can quickly be-
come life threatening. As such, it is a goal for nurses to prevent
neutropenic infections as much as possible. Because the first
sign, and often only sign, of a neutropenic infection is fever, on-
cology staff use a fever as an objective measure to gauge the health
status of the patient. In the past, common nursing interventions
used to prevent neutropenic fever have included protective isola-
tion and neutropenic diet. However, there is little data to support
the use of either. In addition, these measures are difficult to ad-
here to and create a feeling of isolation in the patient. The pur-
pose of this review of literature is to critically analyze current
literature to determine if there are data that indicate that neutro-
penic diet and protective isolation are effective forms of prevent-
ing neutropenic fever. CINAHL, MEDLINE and the Cochrane
database were searched for key words ‘‘neutropenia’’, ‘‘fever’’, ‘‘in-
fection’’, ‘‘prevention’’, ‘‘isolation’’, and ‘‘diet’’, with a time limita-
tion from 2001 until present. Additional articles were identified
from the reference lists of these articles. Twelve articles were
identified as being pertinent to the subject matter. Both qualitative
and quantitative studies were included in the review. The data
found in the literature review does not support the use of neutro-
penic diet or reverse isolation for the prevention of neutropenic
fever. Instead of using resources and time on these interventions,
nurses should emphasize that patients employ proper hand hy-
giene and that fruits and vegetables are thoroughly washed before
eating them.
